source
- Eli Lilly's TuneLab AI platform reaches 100 members and integrates Chai's modelsEli Lilly has built TuneLab, an AI initiative that gives biotech companies free access to a range of artificial‑intelligence tools to support drug discovery and development. The program recently a…
- F2G and Shionogi report positive Phase 3 results for antifungal candidate olorofimF2G and Shionogi announced that their joint antifungal candidate, olorofim, met the primary endpoints in a Phase 3 trial. The data were released Thursday morning and showed the drug performed compa…